Moolec Science (MLEC) Operating Expenses (2022 - 2024)
Moolec Science (MLEC) reported Operating Expenses of -$34.4 million for Q4 2024, down 2142.07% on a YoY basis from $1.7 million in Q1 2024, and down 2066.79% sequentially from -$1.6 million in Q3 2024.
Moolec Science (MLEC) Operating Expenses (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Operating Expenses data on file, last reported at -$34.4 million in Q4 2024.
- For the quarter ending Q4 2024, Operating Expenses fell 2142.07% year-over-year to -$34.4 million; the trailing twelve-month figure through Mar 2026 stood at -$34.4 million (changed N/A YoY), and the FY2024 full-year result was -$135.6 million, down 11.71% from the prior year.
- Operating Expenses eased to -$34.4 million in Q4 2024, from -$1.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.9 million in Q3 2023 to a low of -$34.4 million in Q4 2024.
- A 3-year average of -$4.4 million and a median of -$1.2 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses surged 371.04% in 2023 and plunged 2142.07% in 2024, its largest moves.
- Tracing MLEC's Operating Expenses over 3 years: stood at -$4.5 million in 2022, then soared by 137.44% to $1.7 million in 2023, then sank by 2142.07% to -$34.4 million in 2024.
- Business Quant data shows MLEC's Operating Expenses at -$34.4 million in Q4 2024, -$1.6 million in Q3 2024, and -$2.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -34.42 Mn |
| Sep 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | -8.71 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | -370,632.00 |
| Mar 31, 2023 | -760,984.00 |
| Dec 31, 2022 | -4.50 Mn |
| Sep 30, 2022 | -687,497.00 |
| Jun 30, 2022 | -2.70 Mn |
| Mar 31, 2022 | -135,536.00 |